Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Contezolid

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MicuRx to Present 15 Studies at ESCMID Global 2025
    MicuRx to Present 15 Studies at ESCMID Global 2025

    08 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/micurx-15-clinical-and-preclinical-research-studies-to-be-presented-at-escmid-global-2025-302423147.html

    PR NEWSWIRE
    08 Apr 2025
    Share Share
    MicuRx Contezolid Ph 3 Trial Passes Safety Review For DFI Treatment
    MicuRx Contezolid Ph 3 Trial Passes Safety Review For DFI Treatment

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/micurx-pharmaceutical-contezolid-global-phase-iii-clinical-trial-safety-and-efficacy-evaluation-endorsed-by-data-monitoring-committee-promising-prospects-for-diabetic-foot-infection-treatment-302384542.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    MicuRx Positive Results of Ph 3 Trial for Contezolid in Skin & Soft Tissue Inf.
    MicuRx Positive Results of Ph 3 Trial for Contezolid in Skin & Soft Tissue Inf.

    19 Sep 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/micurx-reports-positive-top-line-results-of-a-china-phase-3-clinical-trial-for-novel-antibiotic-contezolid-in-complicated-skin-and-soft-tissue-infections/?s=69

    BIOSPACE
    19 Sep 2019
    Share Share
    MicuRx Announces Receipt of FDA’s Fast Track Designations for Contezolid
    MicuRx Announces Receipt of FDA’s Fast Track Designations for Contezolid

    21 Sep 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180921005016/en/MicuRx-Announces-Receipt-FDA%E2%80%99s-QIDP-Fast-Track/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    BUSINESSWIRE
    21 Sep 2018
    Share Share
    Hong Kong exchange picks up steam with two biotech IPOs from Innovent, MicuRx
    Hong Kong exchange picks up steam with two biotech IPOs from Innovent, MicuRx

    04 Jul 2018

    // Amber Tong ENDPTS

    https://endpts.com/hong-kong-exchange-picks-up-steam-with-two-biotech-ipos-from-innovent-micurx/

    Amber Tong ENDPTS
    04 Jul 2018
    Share Share